Controversy surrounds Elon Musk, CEO of Tesla and SpaceX, following a Wall Street Journal report alleging his use of illegal drugs at private events.
A recent investigation by the Wall Street Journal has brought to light claims of Elon Musk’s alleged use of drugs like LSD, cocaine, ecstasy, and magic mushrooms at exclusive gatherings since 2017.
The report details specific instances of Musk's supposed drug use. It mentions a 2018 party in Los Angeles where he reportedly took LSD and a 2019 event in Mexico involving magic mushrooms. Musk is also alleged to have used ketamine at a Miami party in 2021, attended by his brother Kimbal Musk.
Musk's behavior has not gone unnoticed by Tesla and SpaceX executives. The report mentions increasing concern over his suitability to lead these major corporations, particularly considering the sensitive nature of SpaceX's federal contracts, which strictly prohibit drug use.
Furthermore, Musk's public antics have had tangible effects on his businesses. His 2018 appearance on Joe Rogan's podcast, where he smoked marijuana, led to a notable drop in Tesla's stock price.
Adding to the complex narrative, Musk's spokesman, Alex Spiro, countered the claims. He insisted that Musk is regularly drug tested and has never failed a test. However, Spiro didn’t elaborate on other alleged inaccuracies in the report.
Concerns about Musk’s behavior surfaced back in 2017. He delivered a slurred and rambling speech to SpaceX employees, raising eyebrows about his sobriety. However, no concrete evidence of drug use during that incident has been presented.
In his authorized autobiography, author Walter Isaacson described Musk's work outbursts as “demon-like.” He reported that Musk often couldn't recall his actions during these episodes. Yet, in the same book, Musk is quoted saying, “I don’t like doing illegal drugs.”
Elon Musk's alleged drug use over the years has raised significant concerns among executives and board members of his companies, Tesla and SpaceX. The Wall Street Journal report details Musk's drug use at specific parties and events since 2017. It raises questions about his leadership of major corporations while potentially under the influence of illegal substances.
Musk has admitted to using ketamine, albeit for medical reasons. He has openly discussed using it to treat depression, a statement separate from the allegations of recreational drug use.
The reported drug use and Musk’s unpredictable behavior have left investors worried. His companies represent approximately $1 trillion in assets, making the implications of his actions far-reaching.
In 2018, Musk tweeted about taking Tesla private. This tweet fueled speculation about his sobriety, adding another layer to the ongoing concerns regarding his decision-making abilities.
The potential impact on investor confidence cannot be understated. With Musk's companies holding such high value, the allegations could have significant repercussions for shareholders and the broader market.
Musk or his representatives have yet to confirm or deny the report. This uncertainty leaves the future of Musk's leadership and the direction of his companies in question.
In conclusion, the Wall Street Journal's report on Elon Musk's alleged drug use has sparked a storm of controversy. From concerns about his ability to lead major corporations to the potential impact on investor confidence, the implications of these allegations are vast. As Musk remains largely silent on the matter, the business world waits for clarity on the truth behind these claims.
